Deerfield, Ill. - Siemens Healthcare (www.siemens.com/diagnostics) introduces the RAPIDPoint 340 and 350 Blood Gas Analyzers for the low- to mid-volume critical care patient testing sites. These two low-maintenance models are small, easy-to-use cartridge-based systems. The simplicity of these systems is ideal for operators in a variety of critical care testing sites including intensive care units, operating or emergency rooms, and the clinical laboratory.

The RAPIDPoint 340 analyzer measures pH and blood gas (oxygen and carbon dioxide). The RAPIDPoint 350 analyzer also measures electrolytes sodium, potassium, calcium or chloride, and hematocrit. All patient test results are available in minutes with minimal operator involvement-an important feature for critical care environments where health care providers may need to make quick therapeutic decisions. Both new systems use a small patient sample size of 75 uL to 120 uL, to accommodate all types of patients. In addition, the systems have the ability to interface with hospital and laboratory information systems.

Siemens' portfolio of blood gas analyzers fits the needs of all sizes and types of laboratories and critical care sites, offering the ability to deliver critical care test results near the bedside or in high-volume hospital environments. Each analyzer has a high-level of test accuracy and ease-of-use features that offer simplicity for any type of operator. The company's RAPIDComm® Data Management and connectivity solution is available for use with many of Siemens' blood gas analyzers. This connectivity solution offers hospital-wide access, making it easier for health care providers to access patient test results throughout their institutions.
The new RAPIDPoint 340 and 350 analyzers are currently available in the United States and Europe. The company anticipates introducing the systems to other countries in the future.

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare is the first integrated healthcare company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. Siemens Healthcare delivers solutions across the entire continuum of care - from prevention and early detection, to diagnosis, therapy and care. Additionally, Siemens Healthcare is the global market leader in innovative hearing instruments. The company employs around 49,000 people worldwide and operates in 130 countries. In the fiscal year 2008 (Sept. 30), Siemens Healthcare reported sales of €11.2 billion, orders of €11.8 billion, and Sector profit of €1.2 billion. Further information can be found by visiting http://www.siemens.com/healthcare.

Back to HCB News

More HCB News